Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Centessa Pharmaceuticals (Nasdaq: CNTA) has announced its management team's participation in three upcoming investor conferences. The company will attend the Guggenheim Healthcare Innovation Conference in Boston on November 13, 2024, with a fireside chat at 9:00 AM ET, the Jefferies London Healthcare Conference on November 19, 2024, at 1:30 PM GMT, and the 7th Annual Evercore HealthCONx Conference in Miami on December 5, 2024, at 10:00 AM ET. Live webcasts and recordings will be accessible through the company's investor relations website.
Centessa Pharmaceuticals (Nasdaq: CNTA) ha annunciato la partecipazione del suo team di gestione a tre conferenze per investitori in arrivo. L'azienda parteciperà alla Guggenheim Healthcare Innovation Conference a Boston il 13 novembre 2024, con un incontro informale alle 9:00 AM ET, alla Jefferies London Healthcare Conference il 19 novembre 2024, alle 1:30 PM GMT, e alla 7a Annual Evercore HealthCONx Conference a Miami il 5 dicembre 2024, alle 10:00 AM ET. Le trasmissioni in diretta e le registrazioni saranno accessibili attraverso il sito web delle relazioni con gli investitori dell'azienda.
Centessa Pharmaceuticals (Nasdaq: CNTA) ha anunciado la participación de su equipo de gestión en tres próximas conferencias para inversores. La compañía asistirá a la Guggenheim Healthcare Innovation Conference en Boston el 13 de noviembre de 2024, con una charla informal a las 9:00 AM ET, a la Jefferies London Healthcare Conference el 19 de noviembre de 2024, a la 1:30 PM GMT, y a la 7ª Conferencia Anual Evercore HealthCONx en Miami el 5 de diciembre de 2024, a las 10:00 AM ET. Las transmisiones en vivo y las grabaciones estarán disponibles a través del sitio web de relaciones con inversores de la compañía.
Centessa Pharmaceuticals (Nasdaq: CNTA)는 세 개의 다가오는 투자자 회의에 경영진 팀이 참가할 것이라고 발표했습니다. 회사는 2024년 11월 13일 보스턴에서 열리는 Guggenheim Healthcare Innovation Conference에 참석하여 오전 9시(동부 표준시)에 편안한 대화를 나누고, 2024년 11월 19일 런던에서 열리는 Jefferies London Healthcare Conference에 오후 1시 30분(그리니치 표준시)에 참석하며, 2024년 12월 5일 마이애미에서 열리는 제7회 Evercore HealthCONx Conference에 오전 10시(동부 표준시)에 참석할 예정입니다. 회사의 투자자 관계 웹사이트를 통해 라이브 웹캐스트 및 녹화를 활용할 수 있습니다.
Centessa Pharmaceuticals (Nasdaq: CNTA) a annoncé la participation de son équipe de direction à trois conférences pour investisseurs à venir. L'entreprise assistera à la Guggenheim Healthcare Innovation Conference à Boston le 13 novembre 2024, avec une discussion informelle à 9h00 ET, à la Jefferies London Healthcare Conference le 19 novembre 2024 à 13h30 GMT, et à la 7e Conférence Annuelle Evercore HealthCONx à Miami le 5 décembre 2024 à 10h00 ET. Des webcasts en direct et des enregistrements seront accessibles via le site web des relations avec les investisseurs de l'entreprise.
Centessa Pharmaceuticals (Nasdaq: CNTA) hat die Teilnahme seines Management-Teams an drei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird an der Guggenheim Healthcare Innovation Conference in Boston am 13. November 2024 um 9:00 Uhr ET, an der Jefferies London Healthcare Conference am 19. November 2024 um 13:30 Uhr GMT und an der 7. jährlichen Evercore HealthCONx Conference in Miami am 5. Dezember 2024 um 10:00 Uhr ET teilnehmen. Live-Webcasts und Aufzeichnungen werden über die Website der Investor Relations des Unternehmens zugänglich sein.
- None.
- None.
BOSTON and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences:
Event: Guggenheim Healthcare Innovation Conference
Date: November 13, 2024
Location: Boston, MA
Fireside Chat: 9:00 AM ET
Event: Jefferies London Healthcare Conference
Date: November 19, 2024
Location: London, UK
Fireside Chat: 1:30 PM GMT
Event: 7th Annual Evercore HealthCONx Conference
Date: December 5, 2024
Location: Miami, FL
Fireside Chat: 10:00 AM ET
Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/.
About Centessa Pharmaceuticals
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients. Our most advanced programs include a hemophilia program, an orexin agonist program for the treatment of narcolepsy and other sleep-wake disorders, and an immuno-oncology program focused on our LockBody® technology platform. We operate with the conviction that each of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit www.centessa.com, which does not form part of this release.
Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com
FAQ
What investor conferences will Centessa Pharmaceuticals (CNTA) attend in November-December 2024?
Where can I watch Centessa Pharmaceuticals (CNTA) investor conference webcasts in 2024?
What time is Centessa Pharmaceuticals' (CNTA) presentation at the Guggenheim Healthcare Conference 2024?
